Literature DB >> 12841155

Selecting medical devices and materials for development in Korea: the analytic hierarchy process approach.

Keun-Tae Cho1, Sung-Min Kim.   

Abstract

Recently, the health industry in Korea has been given greater emphasis. Amid budgetary restrictions, setting the priorities for effective and efficient investment in medical devices and materials has been a key issue in the government sector. This paper shows how the analytic hierarchy process (AHP) can be used in assessing selected medical devices and materials for grants by the Korean Ministry of Health and Welfare. The final results show that unabsorbable suture is the most attractive medical product among 88 evaluated products, followed by i.v. cannula and central venous catheter.

Mesh:

Year:  2003        PMID: 12841155     DOI: 10.1002/hpm.703

Source DB:  PubMed          Journal:  Int J Health Plann Manage        ISSN: 0749-6753


  5 in total

1.  Exploring the perspectives and preferences for HTA across German healthcare stakeholders using a multi-criteria assessment of a pulmonary heart sensor as a case study.

Authors:  Philip Wahlster; Mireille Goetghebeur; Sandra Schaller; Christine Kriza; Peter Kolominsky-Rabas
Journal:  Health Res Policy Syst       Date:  2015-04-28

2.  Medical Device Development Process, and Associated Risks and Legislative Aspects-Systematic Review.

Authors:  Petra Marešová; Blanka Klímová; Jan Honegr; Kamil Kuča; Wan Nur Hidayah Ibrahim; Ali Selamat
Journal:  Front Public Health       Date:  2020-07-30

3.  Applying the Modified Health Belief Model (HBM) to Korean Medical Tourism.

Authors:  Hyun-Jeong Ban; Hak-Seon Kim
Journal:  Int J Environ Res Public Health       Date:  2020-05-22       Impact factor: 3.390

Review 4.  Balancing costs and benefits at different stages of medical innovation: a systematic review of Multi-criteria decision analysis (MCDA).

Authors:  Philip Wahlster; Mireille Goetghebeur; Christine Kriza; Charlotte Niederländer; Peter Kolominsky-Rabas
Journal:  BMC Health Serv Res       Date:  2015-07-09       Impact factor: 2.655

5.  Evaluation of Influenza Intervention Strategies in Turkey with Fuzzy AHP-VIKOR.

Authors:  Funda Samanlioglu
Journal:  J Healthc Eng       Date:  2019-11-19       Impact factor: 2.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.